Ticker >

Infinium Pharmachem share price

Infinium Pharmachem Ltd.

NSE: INFINIUM SECTOR: Chemicals  8851   22   1

326.00
+0.65 (0.20%)
NSE: 04 Nov 4:00 PM

Price Summary

Today's High

₹ 326

Today's Low

₹ 324

52 Week High

₹ 392.5

52 Week Low

₹ 178.05

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyExcellent
The company knows very well the utilization of its assets.
FinancialsAverage
The company could improve upon its asset employment.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

453.67 Cr.

Enterprise Value

453.43 Cr.

No. of Shares

1.39 Cr.

P/E

40.9

P/B

7.86

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  41.5

CASH

8.18 Cr.

DEBT

7.94 Cr.

Promoter Holding

73.05 %

EPS (TTM)

₹  7.97

Sales Growth

20.78%

ROE

27.92 %

ROCE

29.32%

Profit Growth

21.25 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Index Presence

The company is present in 1 Indices.

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year20.78%
3 Year30.9%
5 YearNA

Profit Growth

1 Year21.25%
3 Year59.78%
5 YearNA

ROE%

1 Year27.92%
3 Year45.84%
5 Year41.79%

ROCE %

1 Year29.32%
3 Year33.53%
5 Year30.45%

Debt/Equity

0.1375

Price to Cash Flow

-30.18

Interest Cover Ratio

9.3719

CFO/PAT (5 Yr. Avg.)

0.359278511902818

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Sep 2024 73.05 0.00
Mar 2024 73.05 0.00
Sep 2023 73.05 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good revenue growth of 30.8951072993199% for the Past 3 years.
  • The company has significantly decreased its debt by 18.153999 Cr.
  • Company has been maintaining healthy ROE of 45.840329786654% over the past 3 years.
  • Company has been maintaining healthy ROCE of 33.5304586635349% over the past 3 years.
  • Company has a healthy Interest coverage ratio of 9.3719.
  • The company has an efficient Cash Conversion Cycle of 86.6708 days.
  • Company has a healthy liquidity position with current ratio of 4.133.
  • The company has a high promoter holding of 73.05%.

 Limitations

  • Company has negative cash flow from operations of -15.033654.

Quarterly Result (All Figures in Cr.)

Quarterly Data is not available for this company.Report us

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 36.04 54.56 74.04 101.31 122.36
Total Expenditure 33.41 49.65 65.32 86.1 104.94
Operating Profit 2.63 4.91 8.72 15.21 17.42
Other Income 0.57 0.62 0.93 1.34 1.63
Interest 1.23 1.12 1.66 3 1.78
Depreciation 0.58 0.65 0.58 1.29 2.41
Exceptional Items 0 0 0 0 0
Profit Before Tax 1.39 3.76 7.41 12.26 14.86
Tax 0.37 1.04 1.9 3.12 3.77
Net Profit 1 2.72 5.5 9.15 11.09
Adjusted EPS (Rs.) 1 2.68 5.41 9 7.97

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 1.02 1.02 1.02 5.08 13.92
Total Reserves 3.3 6.03 11.53 16.62 43.84
Borrowings 5.66 5.79 13.62 7.63 5.36
Other N/C liabilities -0.05 -0.06 -0.07 -0.05 0.06
Current liabilities 10.61 17.97 22.88 31.09 14.57
Total Liabilities 20.54 30.75 48.99 60.37 77.74
Assets
Net Block 4.16 4.25 3.74 15.58 16.47
Capital WIP 0 3.86 8.48 0 0.02
Intangible WIP 0 0 0 0 0
Investments 0.26 0.26 0.26 0.34 0.34
Loans & Advances 0.06 0.07 2.57 0.44 0.69
Other N/C Assets 0 0 0 0 0
Current Assets 16.05 22.31 33.93 44 60.23
Total Assets 20.54 30.75 48.99 60.37 77.74
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations 1.39 3.76 7.41 12.26 14.86
Adjustment 1.78 1.76 2.21 4.27 3.91
Changes in Assets & Liabilities -0.47 2.35 1.43 -6.09 -30.16
Tax Paid -0.38 -1.05 -1.91 -3.1 -3.65
Operating Cash Flow 2.32 6.82 9.14 7.35 -15.03
Investing Cash Flow -1.08 -4.59 -7.17 -2.58 -3.29
Financing Cash Flow -1.23 -1.12 -1.66 -3 23.19
Net Cash Flow 0.02 1.1 0.31 1.77 4.86

Corporate Actions

Investors Details

PARTICULARS Sep 2023% Mar 2024% Sep 2024%
promoters 73.05 73.05 73.05
bhadabhai kacharabhai mad... 10.73 10.73 10.73
bharat khodabhai madhani 3.90 3.90 3.90
daxa sanjaykumar patel 4.12 4.12 4.12
krupaben miteshbhai chikh... 0.27 0.27 0.27
lavjibhai ramjibhai chikh... 8.51 8.51 8.51
manjulaben vitthalbhai ch... 0.20 0.20 0.20
mignesh lavjibhai chikhal... 1.63 1.63 1.63
mitesh lavjibhai chikhali... 5.35 5.35 5.35
piyush viththalbhai chikh... 0.90 0.90 0.90
pratikshaben lavjibhai ch... 0.27 0.27 0.27
pravin bhadabhai madhani 13.67 13.67 13.67
sanjaykumar viththalbhai ... 11.48 11.48 11.48
shardaben lavjibhai chikh... 2.24 2.24 2.24
urvishaben piyushbhai chi... 0.81 0.81 0.81
varsha virani 0.27 0.27 0.27
varshaben pravinbhai madh... 8.23 8.23 8.23
vitthalbhai ramjibhai chi... 0.48 0.48 0.48
PARTICULARS Sep 2023% Mar 2024% Sep 2024%
investors 26.95 26.95 26.95
dipen babulal dobariya 2.03 2.14 2.18
vinitkumar maheshkumar do... 1.87 2.06 2.11
patel bhupesh vahalabhai 1.02 1.02 -
swastika investmart ltd 1.25 - -

Annual Reports

Ratings & Research Reports

No Credit and Research reports exist for this company.Report us

Company Presentations

  • PresentationH1FY24 20 May 2024

Infinium Pharmachem Stock Price Analysis and Quick Research Report. Is Infinium Pharmachem an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Infinium Pharmachem stock price today is Rs 326. Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Infinium Pharmachem . 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Infinium Pharmachem has a PE ratio of 40.8967169721375 which is high and comparatively overvalued .

  • Share Price: - The current share price of Infinium Pharmachem is Rs 326. One can use valuation calculators of ticker to know if Infinium Pharmachem share price is undervalued or overvalued.

  • Return on Assets (ROA): - Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Infinium Pharmachem has ROA of 16.0644 % which is a good sign for future performance. (higher values are always desirable)

  • Current ratio: - The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Infinium Pharmachem has a Current ratio of 4.133 .

  • Return on equity: - ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Infinium Pharmachem has a ROE of 27.9245 % .(higher is better)

  • Debt to equity ratio: - It is a good metric to check out the capital structure along with its performance. Infinium Pharmachem has a Debt to Equity ratio of 0.1375 which means that the company has low proportion of debt in its capital.

  • Sales growth: - Infinium Pharmachem has reported revenue growth of 20.7801 % which is fair in relation to its growth and performance. 

  • Operating Margin: - This will tell you about the operational efficiency of the company. The operating margin of Infinium Pharmachem for the current financial year is 14.2349794424504 %.

  • Dividend Yield: - It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Infinium Pharmachem is Rs 0 and the yield is 0 %.

  • Earnings Per Share: - It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Infinium Pharmachem is Rs 7.9713 . The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Infinium Pharmachem in Ticker for free. Also, one can get the intrinsic value of Infinium Pharmachem by using Valuation Calculators, which are available with a Finology ONE subscription. 

Last Updated on:
Brief about Infinium Pharmachem
X